HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Terminated trial tests new drug cocktails for tough cancers
Disease control TerminatedThis early-stage study tested two different drug combinations (TNO155 with either spartalizumab or ribociclib) in adults with advanced solid tumors, including lung, head and neck, and colorectal cancers. The main goal was to find safe doses and understand side effects, not to cur…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Drug combo tested in fight against tough head and neck cancers
Disease control TerminatedThis study tested whether adding an experimental drug called magrolimab to other cancer therapies could help control advanced head and neck cancer. It involved 193 people whose cancer had spread or returned and could not be cured with surgery or radiation. The main goals were to …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
First human test of new cancer drug halted
Disease control TerminatedThis early-stage study aimed to find a safe dose of a new drug called HFB301001 for adults with advanced cancers that had stopped responding to standard treatments. It involved 31 patients with cancers like sarcoma, kidney, liver, and melanoma. The trial was designed to test incr…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer that had stopped responding to hormone therapy, as well as other solid tumors. The trial aimed to see if the drug could slow cancer growth and shrink tumors. The study …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Early cancer drug trial halted after single patient
Knowledge-focused TerminatedThis early-phase study aimed to understand how a new packaging method for an existing chemotherapy drug (paclitaxel) affects immune cells within head and neck cancer tumors. The goal was to gather knowledge to help design future treatments, not to directly treat patients in this …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC